Results 11 to 20 of about 50,655 (275)

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency

open access: yesHeliyon, 2022
Acquired angioedema due to C1-inhibitor deficiency (C1–INH-AAE) is a rare disease that can be diagnosed via complement testing. It often accompanies lymphoproliferative underlying diseases.
Zsofia Polai   +4 more
doaj   +1 more source

Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid

open access: yesLife, 2022
Background: Late hypersensitivity reactions (HSRs) to the BNT162b2-vaccine have raised concerns regarding its safety, particularly as further immunizations are required. The yield of skin testing with the BNT162b2v is unclear, as well as the risk factors
Ramit Maoz-Segal   +7 more
doaj   +1 more source

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

open access: yesAllergy, Asthma & Clinical Immunology, 2022
Background Hereditary angioedema (HAE) is characterized by potentially severe and life-threatening attacks of localized swelling. Prophylactic therapies are available, including attenuated androgens. Efficacy of attenuated androgens has not been assessed
Marcus Maurer   +11 more
doaj   +1 more source

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

open access: yesClinical and Translational Allergy, 2021
Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla   +8 more
doaj   +1 more source

Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome. [PDF]

open access: yesEJHaem
eJHaem, Volume 7, Issue 1, February 2026.
Suárez EU   +2 more
europepmc   +2 more sources

C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Autoantibodies against C1-inhibitor (C1-INH-Ab) have a diagnostic value in acquired angioedema due to C1-inhibitor deficiency (C1-INH-AAE), even though antibodies can circulate in complexes, which can be undetectable by proven methods. Our aim
Zsofia Polai   +6 more
doaj   +1 more source

Hypersensitivity reactions amongst Hungarian Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency

open access: yesWorld Allergy Organization Journal, 2023
Background: In hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE), bradykinin-mediated submucosal and/or subcutaneous angioedema dominates the clinical picture.
Hanga Réka Horváth, MD   +5 more
doaj   +1 more source

Risk of angioedema following invasive or surgical procedures in HAE type I and II : the natural history [PDF]

open access: yes, 2013
Background: Hereditary angioedema (HAE), caused by deficiency in C1-inhibitor (C1-INH), leads to unpredictable edema of subcutaneous tissues with potentially fatal complications.
Aygören-Pürsün, Emel   +4 more
core   +1 more source

Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema

open access: yesClinical and Translational Allergy, 2023
Background Hereditary angioedema (HAE) with C1‐inhibitor deficiency (C1‐INH‐HAE) is a rare disease caused by low level (type I) or dysfunction (type II) of the C1‐inhibitor protein with subsequent reduction of certain complement protein levels.
Marius‐Ionuţ Iuraşcu   +12 more
doaj   +1 more source

C1 inhibitor deficiency: 2014 United Kingdom consensus document [PDF]

open access: yes, 2015
C1 inhibitor deficiency is a rare disorder manifesting with recurrent attacks of disabling and potentially life-threatening angioedema. Here we present an updated 2014 United Kingdom consensus document for the management of C1 inhibitor-deficient ...
Ashworth, F   +11 more
core   +3 more sources

Home - About - Disclaimer - Privacy